Abstract
The development of an effective vaccine against smallpox led to its rapid eradication. This success has led to increased optimism regarding the prevention of other infectious diseases, including leishmaniases. However, the prospect of achieving a similar success in the case of the leishmaniases, where sandfly vectors and, in many cases, animal reservoirs are involved, is nigh impossible. However, vaccination in conjunction with control of sandfly vectors and reservoir animals could lead to a substantial reduction in the occurrence of cases. In the advent of a vaccine against Indian visceral leishmaniasis, which is considered to be anthroponotic, successful control, even if not total eradication, should be possible, if an effective vector control programme is carried out simultaneously.
Preview
Unable to display preview. Download preview PDF.
References
Adler, S., 1964, Leishmania, Adv. Parasit., 2:35.
Alexander, J., 1982, A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana, Trans.R.Soc. Trop. Med. Hyg., 76:646.
Antunes, F., Carvalho, C., Tavares, L., Botas, J., Forte, M., del Rio, A.M., Dutschmann, L., Costa, A., Abranches P., Silva Pereira, C., Paiva, J.E.D., Carvalho Araujo, F., and Baptista, A., 1987, Visceral leishmaniasis recrudescence in a patient with AIDS. Trans. R. Soc. Trop. Med. Hyg., 81:595.
Badaro, R., Jones, T.C., Carvalho, E.M., Sampaio, D., Reed, S.G., Barrai, A., Teixeira, R., and Johnson, Jr., W.D., 1986, New perspectives on a subclinical form of visceral leishmaniasis, J. Inf. Dis., 154:1003.
Bryceson, A.D.M., 1970, Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment, Trans. R. Soc. Trop. Med. Hyg., 64:369.
Corkhill, N.L., 1948a, Activation of latent kala-azar and malaria by battle experience, Ann. Trop. Med. Parasit., 42:224.
Corkhill, N.L., 1948b, Activation of latent kala-azar by malaria and relapsing fever, Ann. Trop. Med. Parasit., 42:230.
Gastaut, J.A., Blanc, A.P., Imbert, C., Sebahoun, G., and Carcassonne, Y., 1981, Leishmaniose viscerale mediterranéenne de l’adulte au cours de la rémission complète d’une leucémie aigué lymphoblastique, Nouv. Press. Med., 10:1332.
Greenblatt, C.L., 1980, The present and future of vaccination for cutaneous leishmaniasis, in: “New Developments With Human and Veterinary Vaccines,” A. Mizrahi, I. Hertman, M. A. Klingberg, and A. Kohn, eds, Alan R. Liss, New York.
Greenblatt, C.L., 1985, Vaccination for leishmaniasis, In: “Leishmaniasis,” K.-P. Chang and R.S. Bray, eds, Elsevier Science Publishers, Amsterdam.
Greenblatt, C.L., Spira, D.T., Montilio, B., and Gerichter, H., 1980, An improved protocol for the preparation of a frozen promastigote vaccine for cutaneous leishmaniasis. J. Biol. Stand., 8:227.
Guirges, S.Y., 1971, Natural and experimental re-infection of man with oriental sore, Ann. Trop. Med. Parasit., 65: 197.
Gunders, A.E., 1987, Vaccination: past and future role in control, in: “The Leishmaniases in Biology and Medicine (Volume II),” W. Peters and R. Killick-Kendrick, eds, Academic Press, London.
Handman, E., 1986, Leishmaniasis: antigens and host-parasite interactions, in: “Parasite antigens Towards New Strategies for Vaccines,” T.W. Pearson, ed., Marcel Dekker, New York and Basel.
Handman, E., Spira, D.T., Zuckerman, A., and Montilio, B., 1974, Standard-ization and quality control of Leishmania tropica vaccine, J.Biol. Stand., 2:223.
Hauteville, D., Chagnon, A., Camilleri, G., and Herne, N., 1980, Leishman-iose viscérale mécliterranéenne chez un leucémique en rémission, Nouv. Press. Med., 31:1713.
Herne, N., Hauteville, D., Verdier, M., Chagnon, A., Abgrall, J., and Raillat, A., 1980, Kala-azar méditerranéen chez deux adultes traités par immuno-suppresseurs, Rev. Med. Int., 1:237.
Heyneman, D., 1971, Immunology of leishmaniasis, Bull. Wld Hlth Org., 44: 499.
Hill, J.O., North, R.J., and Collins, F.M., 1983, Advantages of measuring changes in the number if viable parasites in murine models of experimental cutaneous leishmaniasis, Inf. Immun., 39:1087.
Holbrook, T.W., Cook, J.A., and Parker, B.W., 1981, Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes, Am. J. Trop. Med. Hyg., 30:762.
Howard, J.G., Nicklin, S., Hale, C., and Liew, Y., 1982, Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection, J.Immun., 129 :2206.
Killick-Kendrick, R., Bryceson, A.D.M., Peters, W., Evans, D.A., Leaney, A.J., and Rioux, J.-A., 1985, Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major, Trans. R. Soc. Trop. Med. Hyg., 79:363.
Kurotchkin, T.J., 1931, An attempt to immunize hamsters against kala-azar, Natl Med. J. China, 18:458.
Leclerc, C., Modabber, F., Deriaud, E., and Chedid, L., 1981, Systematic infection of Leishmania tropica (major) in various strains of mice, Trans. R. Soc. Trop. Med. Hyg., 75:851.
Lemma, A., and Cole, L., 1974, Leishmania enriettii: radiation effects and evaluation of radioattenuated organisms for vaccination. Expl Parasit., 35:161.
Mayrink, W., da Costa, C.A., Magalhães, P.A., Melo, M.N., Dias, M., Oliveiri Lima, A., Michalick, M.S., and Williams, P., 1979, A field trial of a vaccine against American dermal leishmaniasis, Trans.R. Soc. Trop. Med. Hyg., 73:385.
Mayrink, W., Williams, P., da Costa, C.A., Magalhaes, P.A., Melo, M.N., Dias, M., Oliveira Lima, A., Michalick, M.S.M., Ferreira Carvalho, E., Barros, G.C., Sessa, P.A., and de Alencar, J.T.A., 1985, An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil, Trans. R. Soc. Trop.Med. Hyg., 79:259.
Nadim, A., 1984, Immunity to cutaneous leishmaniasis, Trans. R. Soc. Trop. Med. Hyg., 78: 848.
Napier, L.E., 1946, “The Principles and Practice of Tropical Medicine,” MacMillan, New York.
Peters, W., and Killick-Kendrick, R., 1987, Editorial note added in proof, in: “The Leishmaniases in Biology and Medicine (Volume II),” W. Peters and R. Killick-Kendrick, eds, Academic Press, London.
Peters, W., and Killick-Kendrick, R., 1987, Editorial note added in proof, in: “The Leishmaniases in Biology and Medicine (Volume II),” W. Peters and R. Killick-Kendrick, eds, Academic Press, London.
Schnur, L.F., and Jacobson, R.L., 1987, Appendix III Parasitological Techniques, in: “The Leishmaniases in Biology and Medicine (Volume I),” W. Peters and R. Killick-Kendrick, eds, Academic Press, London.
Schnur, L.F., Slutzky, G.M. and Greenblatt, C.L., 1983a, Naturally attenuated strains of Leishmania do not elicit a protective response in Syrian hamsters, Israel J. Med. Sci., 19:1112.
Schnur, L.F., Slutzky, G.M., and Greenblatt, C.L., 1983b, Appraisal of a dead polyvalent vaccine against leishmaniasis, J. Protozool.(Suppl.), 30:56A.
Schnur, L.F., Zuckerman, A., and Montilio, B., 1973, Dissemination of leish-manias to the organs of Syrian hamsters following intrasplenic inoc-ulation of promastigotes, Expl Parasit., 34:432.
WHO, 1984, “The Leishmaniases”, Technical Report Series 701”,
WHO, Geneva. Serebryakov, V.A., Karakhodzhaeva, S. Kh., Dzhumaev, M.D., 1972, On the effect of leishmanial vaccinations on the dynamics of immunity to diphtheria under conditions of second vaccination with adsorbed diphtheria-pertussis-tetanus (DPT) vaccine, Med.Parazitol. 41:303.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schnur, L.F. (1989). Premunition, A Possible Limitation in the Prevention of the Leishmaniases by Vaccination. In: Hart, D.T. (eds) Leishmaniasis. NATO ASI Series, vol 171. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1575-9_46
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1575-9_46
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8862-6
Online ISBN: 978-1-4613-1575-9
eBook Packages: Springer Book Archive